Dr. Luigi Warren
Ph.D. is President & CEO of Cellular Reprogramming,
a biotechnology company located in La Jolla, California. The company produces
human induced pluripotent stem cells (iPSCs) for researchers in academia
and pharma using mRNA reprogramming, a clinically-relevant alternative
to viral reprogramming which Luigi pioneered during postdoctoral
work at Harvard Medical School.
His patents include Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs and Kit for making induced pluripotent stem cells using modified RNAs. His papers include Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA, Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR, Stem cells and aging in the hematopoietic system, and Transcriptional instability is not a universal attribute of aging.
Luigi earned his BSc in Electronic Engineering with Computer Science at University College London in 1982. He earned his BSc in Biology at Columbia University in 2001 and his Ph.D. in Biology at the California Institute of Technology in 2007.
Watch his talk Messenger RNA Reprogramming and the Path to Clinically Relevant iPSCs. Read his LinkedIn profile. Follow his Twitter feed.